Literature DB >> 29351434

Cub domain-containing protein 1 negatively regulates TGF-β signaling and myofibroblast differentiation.

Nina Noskovičová1, Katharina Heinzelmann1, Gerald Burgstaller1, Jürgen Behr2,3, Oliver Eickelberg1,4.   

Abstract

Fibroblasts are thought to be the prime cell type for producing and secreting extracellular matrix (ECM) proteins in the connective tissue. The profibrotic cytokine transforming growth factor-β1 (TGF-β1) activates and transdifferentiates fibroblasts into α-smooth muscle actin (α-SMA)-expressing myofibroblasts, which exhibit increased ECM secretion, in particular collagens. Little information, however, exists about cell-surface molecules on fibroblasts that mediate this transdifferentiation process. We recently identified, using unbiased cell-surface proteome analysis, Cub domain-containing protein 1 (CDCP1) to be strongly downregulated by TGF-β1. CDCP1 is a transmembrane glycoprotein, the expression and role of which has not been investigated in lung fibroblasts to date. Here, we characterized, in detail, the effect of TGF-β1 on CDCP1 expression and function, using immunofluorescence, FACS, immunoblotting, and siRNA-mediated knockdown of CDCP1. CDCP1 is present on interstitial fibroblasts, but not myofibroblasts, in the normal and idiopathic pulmonary fibrosis lung. In vitro, TGF-β1 decreased CDCP1 expression in a time-dependent manner by impacting mRNA and protein levels. Knockdown of CDCP1 enhanced a TGF-β1-mediated cell adhesion of fibroblasts. Importantly, CDCP1-depleted cells displayed an enhanced expression of profibrotic markers, such as collagen V or α-SMA, which was found to be independent of TGF-β1. Our data show, for the very first time that loss of CDCP1 contributes to fibroblast to myofibroblast differentiation via a potential negative feedback loop between CDCP1 expression and TGF-β1 stimulation.

Entities:  

Keywords:  cell signaling; cell surface; fibroblast; myofibroblast differentiation; transforming growth factor-β

Mesh:

Substances:

Year:  2018        PMID: 29351434     DOI: 10.1152/ajplung.00205.2017

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  Theranostic Targeting of CUB Domain Containing Protein 1 (CDCP1) in Pancreatic Cancer.

Authors:  Anna Moroz; Yung-Hua Wang; Jeremy M Sharib; Junnian Wei; Ning Zhao; Yangjie Huang; Zhuo Chen; Alexander J Martinko; Jie Zhuo; Shion A Lim; Lydia H Zhang; Youngho Seo; Sean Carlin; Kevin K Leung; Eric A Collisson; Kimberly S Kirkwood; James A Wells; Michael J Evans
Journal:  Clin Cancer Res       Date:  2020-04-27       Impact factor: 12.531

Review 2.  TGF‑β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis (Review).

Authors:  Zhimin Ye; Yongbin Hu
Journal:  Int J Mol Med       Date:  2021-05-20       Impact factor: 4.101

3.  Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease.

Authors:  Jose-Ramon Blanco; María-Jesús Cobos-Ceballos; Francisco Navarro; Isabel Sanjoaquin; Carlos Armiñanzas; Enrique Bernal; Luis Buzon-Martin; Miguel Viribay; Laura Pérez-Martínez; Simona Espejo-Pérez; Borja Valencia; Jesus Guzman-Aguilar; Juan-Jose Ruiz-Cubillan; Consuelo Alcalde; Fernando Gustavo Gutierrez-Herrero; Julian Olalla; Eva-Maria Andres-Esteban; Bernabe Jurado-Gamez; Javier Ugedo
Journal:  Aging (Albany NY)       Date:  2022-02-16       Impact factor: 5.682

4.  Phenotypic drug screening in a human fibrosis model identified a novel class of antifibrotic therapeutics.

Authors:  Michael Gerckens; Kenji Schorpp; Francesco Pelizza; Melanie Wögrath; Kora Reichau; Huilong Ma; Armando-Marco Dworsky; Arunima Sengupta; Mircea Gabriel Stoleriu; Katharina Heinzelmann; Juliane Merl-Pham; Martin Irmler; Hani N Alsafadi; Eduard Trenkenschuh; Lenka Sarnova; Marketa Jirouskova; Wolfgang Frieß; Stefanie M Hauck; Johannes Beckers; Nikolaus Kneidinger; Jürgen Behr; Anne Hilgendorff; Kamyar Hadian; Michael Lindner; Melanie Königshoff; Oliver Eickelberg; Martin Gregor; Oliver Plettenburg; Ali Önder Yildirim; Gerald Burgstaller
Journal:  Sci Adv       Date:  2021-12-22       Impact factor: 14.957

5.  Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis.

Authors:  Mujdat Zeybel; Muhammad Arif; Xiangyu Li; Ozlem Altay; Hong Yang; Mengnan Shi; Murat Akyildiz; Burcin Saglam; Mehmet Gokhan Gonenli; Buket Yigit; Burge Ulukan; Dilek Ural; Saeed Shoaie; Hasan Turkez; Jens Nielsen; Cheng Zhang; Mathias Uhlén; Jan Borén; Adil Mardinoglu
Journal:  Adv Sci (Weinh)       Date:  2022-02-07       Impact factor: 16.806

6.  Peimine ameliorates pulmonary fibrosis via the inhibition of M2-type macrophage polarization through the suppression of P38/Akt/STAT6 signals.

Authors:  Ze-Hui Cai; Yan-Ge Tian; Jun-Zi Li; Peng Zhao; Jian-Sheng Li; Xue Mei; Yun-Ping Bai
Journal:  Biosci Rep       Date:  2022-10-28       Impact factor: 3.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.